Sign in
4/A

Changes in Ownership

MANNKIND CORP Filed Acc 0001209191-22-047428

EVP Endocrine Business Unit acquired 36,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Galindo Alejandro EVP Endocrine Business Unit 2022-02-28 Grant or award +36,900 $2.71 $99,999 576,690 D: show line 1 in the form
Loading xslF345X03/doc4a.xml…